Published in Biochem Biophys Res Commun on December 30, 1993
Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med (2005) 4.31
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med (1996) 3.33
Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med (1995) 2.83
Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci U S A (1995) 2.36
Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J Clin Invest (1997) 1.69
Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med (1997) 1.61
Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J Exp Med (1995) 1.57
T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophila. J Exp Med (1996) 1.53
Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med (1997) 1.43
Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res (2001) 1.31
Eosinophils in the pathogenesis of allergic airways disease. Cell Mol Life Sci (2007) 1.26
Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J Exp Med (1998) 1.25
Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest (1997) 1.22
Chemokines and asthma: redundancy of function or a coordinated effort? J Clin Invest (1999) 1.16
Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation. Clin Exp Immunol (1998) 1.11
"Ultimate activation" of eosinophils in vivo: lysis and release of clusters of free eosinophil granules (Cfegs). Thorax (1997) 1.05
Antibody to VLA-4, but not to L-selectin, protects neuronal M2 muscarinic receptors in antigen-challenged guinea pig airways. J Clin Invest (1997) 1.04
Lung eosinophilia is dependent on IL-5 and the adhesion molecules CD18 and VLA-4, in a guinea-pig model. Immunology (1995) 0.92
A low dose of Mycoplasma pneumoniae infection enhances an established allergic inflammation in mice: the role of the prostaglandin E2 pathway. Clin Exp Allergy (2009) 0.91
Chemokines in the limbal form of vernal keratoconjunctivitis. Br J Ophthalmol (2000) 0.90
Intrabronchial infection of rhesus macaques with simian varicella virus results in a robust immune response in the lungs. J Virol (2014) 0.88
Eotaxin: a VIC (very important chemokine) of allergic inflammation? J Clin Invest (1996) 0.86
Effects of overexpression of IL-10, IL-12, TGF-beta and IL-4 on allergen induced change in bronchial responsiveness. Respir Res (2006) 0.86
Soluble mimics of a chemokine receptor: chemokine binding by receptor elements juxtaposed on a soluble scaffold. Protein Sci (2003) 0.85
Backbone dynamics of the human CC chemokine eotaxin: fast motions, slow motions, and implications for receptor binding. Protein Sci (1999) 0.83
Expression of eotaxin in 3T3-L1 adipocytes and the effects of weight loss in high-fat diet induced obese mice. Nutr Res Pract (2011) 0.82
Chemokines and their role in airway hyper-reactivity. Respir Res (2000) 0.81
Regulation of eotaxin-3/CCL26 expression in human monocytic cells. Immunology (2010) 0.81
Eotaxin and eotaxin receptor (CCR3) expression in Sephadex particle-induced rat lung inflammation. Int J Exp Pathol (1999) 0.80
Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme. Br J Pharmacol (2001) 0.78
Eotaxin and asthma: some answers, more questions. Clin Exp Immunol (1999) 0.78
Bacterial artificial chromosome derived simian varicella virus is pathogenic in vivo. Virol J (2013) 0.78
Human eotaxin induces eosinophil extravasation through rat mesenteric venules: role of alpha4 integrins and vascular cell adhesion molecule-1. Immunology (1999) 0.78
Intermediary quantitative traits--an alternative in the identification of disease genes in asthma? Genes Immun (2013) 0.77
IL-33 mediates reactive eosinophilopoiesis in response to airborne allergen exposure. Allergy (2016) 0.76
Inhibition by new glucocorticoid antedrugs [16α, 17α-d] isoxazoline and [16α, 17α-d]-3'-hydroxy-iminoformyl isoxazoline derivatives of chemotaxis and CCL26, CCL11, IL-8, and RANTES secretion. J Interferon Cytokine Res (2013) 0.76
Chemokines: structure, receptors and functions. A new target for inflammation and asthma therapy? Mediators Inflamm (1996) 0.76
Eotaxin expression in Sephadex-induced lung injury in rats. Am J Pathol (1999) 0.75
Impact of irradiation and immunosuppressive agents on immune system homeostasis in rhesus macaques. Clin Exp Immunol (2015) 0.75
Th2 cells and cytokine networks in allergic inflammation of the lung. Mediators Inflamm (1995) 0.75
Repeated Mouse Lung Exposures to Stachybotrys chartarum Shift Immune Response from Type 1 to Type 2. Am J Respir Cell Mol Biol (2016) 0.75
Failure of sputum eosinophilia after eotaxin inhalation in asthma. Thorax (2004) 0.75
An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis. Inflammation (2016) 0.75
Ligand-based molecular design of 4-benzylpiperidinealkylureas and amides as CCR3 antagonists. J Mol Model (2009) 0.75
Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature (1981) 6.36
Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature (1973) 6.34
Calcitonin gene-related peptide is a potent vasodilator. Nature (1985) 6.13
Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med (1996) 5.53
Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med (1994) 4.36
Role of prostaglandin-mediated vasodilatation in inflammation. Nature (1977) 3.95
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science (1997) 3.70
Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation. Br J Pharmacol (1979) 3.58
Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol (2000) 3.05
Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med (1995) 2.83
Lung volume reduction surgery for emphysema. Med J Aust (1997) 2.70
Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature (1988) 2.54
Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol (1985) 2.38
Sequence variability and developmental expression of S-alleles in self-incompatible and pseudo-self-compatible petunia. Plant Cell (1990) 2.15
Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a. J Exp Med (1981) 2.12
Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol (1999) 2.09
Adhesion of a human fecal Escherichia coli strain to mouse colonic mucus. Infect Immun (1985) 2.07
Rapid opioid detoxification under anaesthesia. Hosp Med (1998) 1.98
Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol (1998) 1.94
Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology (1992) 1.93
Evidence that neutrophil accumulation induced by interleukin-1 requires both local protein biosynthesis and neutrophil CD18 antigen expression in vivo. Br J Pharmacol (1988) 1.90
NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem (1999) 1.89
A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives. Br J Clin Pharmacol (2000) 1.84
The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J (2009) 1.81
Evaluation of factors affecting the membrane filter technique for testing drinking water. Appl Environ Microbiol (1982) 1.80
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol (1997) 1.69
Cloning of cDNA for pyruvate, Pi dikinase from maize leaves. Nucleic Acids Res (1983) 1.69
Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol (1986) 1.68
LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin. Am J Respir Cell Mol Biol (2001) 1.64
Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today (2000) 1.62
Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol (1993) 1.62
Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med (1997) 1.61
An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J Exp Med (1996) 1.58
Detection of the complement fragment C5a in inflammatory exudates from the rabbit peritoneal cavity using radioimmunoassay. J Exp Med (1983) 1.56
Cyclooxygenase-2: regulation and relevance in inflammation. Biochem Pharmacol (1995) 1.56
Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease. Intern Med J (2003) 1.55
The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. Immunology (1991) 1.55
A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J Exp Med (1993) 1.53
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev (2006) 1.51
Impact of graft ischemic time on outcomes after bilateral sequential single-lung transplantation. Ann Thorac Surg (1999) 1.50
Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood (1998) 1.49
Identification and characterization of mouse small intestine mucosal receptors for Escherichia coli K-12(K88ab). Infect Immun (1986) 1.47
The MES-1 murine enhancer element is closely associated with the heterogeneous 5' ends of two divergent transcription units. Mol Cell Biol (1986) 1.47
Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature (1988) 1.46
Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. Eur J Pharmacol (1990) 1.45
Prostacyclin (PGI2) potentiates bradykinin-induced plasma exudation in rabbit skin [proceedings]. Br J Pharmacol (1978) 1.44
Interactions between the tachykinins and calcitonin gene-related peptide lead to the modulation of oedema formation and blood flow in rat skin. Br J Pharmacol (1989) 1.43
Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem Biophys Res Commun (1994) 1.43
Imaging the Fano lattice to 'hidden order' transition in URu(2)Si(2). Nature (2010) 1.42
Endothelin induces potent microvascular constriction. Br J Pharmacol (1988) 1.42
29-gauge spinal needles. Br J Anaesth (1991) 1.40
An assessment of the ability of a silver-releasing device to prevent bacterial contamination of urethral catheter drainage systems. Br J Urol (1996) 1.40
The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin. Prostaglandins (1981) 1.40
Current status of genitourinary fistula. Obstet Gynecol (1988) 1.40
Chemical mediators of vascular responses in inflammation: a two mediator hypothesis [proceedings]. Br J Pharmacol (1977) 1.39
Primary pulmonary hypertension: new reasons for optimism? Med J Aust (1998) 1.39
Alpha 1-adrenoceptor classification: sharpening Occam's razor. Trends Pharmacol Sci (1994) 1.38
Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase. Ann Rheum Dis (1990) 1.38
Proceedings:Simultaneous measurement of local plasma exudation and blood flow changes induced by intradermal injection of vasoactive substances, using [131I]albumen and 133Xe. J Physiol (1976) 1.38
Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J Immunol (1997) 1.38
An investigation into the 'carry over' effect of neurostimulation in the treatment of angina pectoris. Int J Clin Pract (2004) 1.38
Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J Immunol (1999) 1.38
Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin. Br J Pharmacol (1982) 1.35
Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res (2001) 1.31
Endometriosis in 1,000 consecutive celiotomies: incidence and management. Am J Obstet Gynecol (1977) 1.30
A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry. J Biol Chem (2000) 1.29
Human C5a des Arg increases vascular permeability. J Immunol (1981) 1.28
Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J Clin Invest (1997) 1.27
Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br J Pharmacol (1993) 1.26
Measurement of rate of extravasation of plasma protein in inflammatory responses in guinea-pig skin using a continuous recording method. Br J Exp Pathol (1974) 1.26
Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J Immunol (2000) 1.26
Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J Exp Med (1998) 1.25
Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. J Immunol (1997) 1.24
Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. J Clin Invest (1995) 1.23
Eosinophil accumulation induced by human interleukin-8 in the guinea-pig in vivo. Immunology (1993) 1.23
Pho23 is associated with the Rpd3 histone deacetylase and is required for its normal function in regulation of gene expression and silencing in Saccharomyces cerevisiae. J Biol Chem (2001) 1.19
Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages. J Immunol (1995) 1.17
Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database. Hum Reprod (1999) 1.17